These findings highlight the involvement of miR-17-3p in AAA development by targeting SDC1 to damage the glycocalyx and emphasize the potential of AS-IV in alleviating AAA by inhibiting miR-17-3p expression to preserve the glycocalyx. Here, SDC1 is linked to triple-A syndrome.